C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2001
11/08/2001	WO2001002340B1 Novel aminoindanes
11/08/2001	US20010039344 Antidiabetic agents
11/08/2001	US20010039277 Neuropeptide Y antagonists such as 2-chloro-5-(4-(3,4-dich loro-phenyl)-1H-imidazol-2-yl)-pyridine
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2402445A1 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321145A Diphenyl compounds substd. by camphor or hydantoin derivs. as sunscreen compositions
11/07/2001	CN1320597A Antifungal and its preparation method and intermediate
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313349 Electroluminescent intermediate
11/06/2001	US6313345 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/06/2001	US6313311 Imidazole derivatives having affinity for alpha2 receptors
11/06/2001	US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001	US6313119 Vitronectin receptor antagonists
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312538 Chemical compound suitable for use as an explosive, intermediate and method for preparing the compound
11/01/2001	WO2001081353A1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
11/01/2001	WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001	WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators
11/01/2001	WO2001081317A1 Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081315A2 Amino-imidazole derivatives for treating cancer
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	US20010036957 Diabetic neuropathy, nephropathy, ophthalimopathy, arteriosclerosis
11/01/2001	US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	CA2372673A1 Cyclic amidine compounds
11/01/2001	CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP0888292B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY ALPHAvBETA3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/31/2001	EP0869946B1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/31/2001	EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001	EP0819124B1 Azole compounds with antimycotic activity for human and veterinary use
10/31/2001	EP0754180B1 Anti-helicobacter ester and carbamate derivatives of azolones
10/31/2001	DE10020861A1 Preventing premature polymerization of compounds with O- or N-vinyl groups using alkali(ne earth) metal alcoholates optionally in the form of novel polymerizable vinyl compounds
10/31/2001	DE10020818A1 2,6-Diamino-6-methyl-heptansäure und Derivate, Verfahren zu deren Herstellung und deren Verwendung 2,6-diamino-6-methyl-heptanoic acid and derivatives, processes for their preparation and their use
10/31/2001	CN1320034A Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacturing of medicament for intraspinal, intrathecal or epidural edministration
10/31/2001	CN1074009C Storage-stable, flame retardant-containing polyol component
10/30/2001	US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310084 Inhibitors of metalloproteases involved in tissue degradation
10/30/2001	US6310067 Urocanic acid derivatives
10/25/2001	WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001	WO2001079179A2 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase
10/25/2001	WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2001025215A3 Method for selectively dissociating cyclic carboxylic acid anhydrides
10/25/2001	WO2000061541A8 Pharmaceutical compounds
10/25/2001	US20010034457 Comprises reacting iminodiacetonitrile with aldehydes and hydrogen cyanide or alkali metal cyanides; useful as biodegradable complexing agents for alkali metal and heavy metal ions
10/25/2001	CA2406032A1 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase
10/25/2001	CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/24/2001	EP1148052A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor
10/24/2001	EP1148051A2 1,3-dialkyl-2-imidazolidinones and a manufacturing process therefor
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001	EP0837679B1 2-(1h-4(5)-imidazoyl) cyclopropyl derivatives
10/24/2001	EP0749419B1 Oxime derivatives and their use as pesticides
10/24/2001	CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319091A Cyanophenyl derivatives
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1318539A Amino acid-iodine complex
10/24/2001	CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/23/2001	US6307086 Preparation of long-chain substituted nitrilotriacetonitriles from iminodiacetonitrile, long-chain aldehyde and hcn or alkali metal cyanide or from an alpha-amino long-chain nitrile, formaldehyde and hcn or alkali metal cyanide
10/23/2001	US6307058 Useful in paper and textile applications and in improving wet adhesion properties of latex paints.
10/23/2001	US6307057 Catalyze enantioselective reactions, e.g., diels-alder reactions
10/23/2001	US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/18/2001	WO2001077082A1 Naphthalene derivatives
10/18/2001	WO2001077081A1 Imidazole carbenes
10/18/2001	WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001	WO2001077076A1 Novel naphthalene derivatives
10/18/2001	WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001	WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
10/18/2001	US20010031896 By reacting with 2,2,2-trifluoroethylformate in an optionally buffered solvent; by-product inhibition
10/18/2001	US20010031877 Eprosartan dihydate and a process for its production and formulation
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031732 Free radical scavenger in cosmetics, drugs
10/17/2001	EP1146037A1 Process for the preparation of optically active amino alcohols
10/17/2001	EP1144399A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144370A2 Thyroid receptor ligands
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors

1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 345